Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer

F. Ciardiello, T. Troiani, F. Caputo, M. De Laurentiis, G. Tortora, G. Palmieri, F. De Vita, M. R. Diadema, M. Orditura, G. Colantuoni, C. Gridelli, G. Catalano, S. De Placido, A. R. Bianco

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences